Design Therapeutics, Inc - DSGN - Share Chat

[Freetrade_Team]

This US-based biotechnology firm specialises in therapies for serious degenerative disorders caused by nucleotide repeat expansions.

IPOs 26/3/21.

[Jakilad (Mark Stephenson)]

Any idea what time this will go live?